CTI 1060: A Phase II Clinical Trial of Arsenic Trioxide and Dexamethasone as Therapy for Relapsed or Refractory Multiple Myeloma
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 25 Jul 2014
At a glance
- Drugs Arsenic trioxide (Primary) ; Dexamethasone
- Indications Multiple myeloma
- Focus Therapeutic Use
- Sponsors CTI BioPharma
- 25 Jul 2014 Last checked against ClinicalTrials.gov record.
- 10 Sep 2005 New trial record.